摘要
目的分析在缺血性脑血管疾病患者治疗中应用血塞通注射液联合增强型体外反搏的价值。方法选取我院收治的缺血性脑血管疾病患者110例,将患者随机分为对照组和联合组,各55例。对照组应用增强型体外反搏治疗,联合组在对照组基础上联合血塞通注射液治疗,比较两组治疗效果、治疗前后超敏C反应蛋白(hs-CPR)、内皮素(ET-1)水平及神经功能评分。结果治疗后,两组患者的hs-CPR、ET-1水平和NHISS评分均降低,且联合组低于对照组(P<0.05);联合组的治疗总有效率高于对照组(P<0.05)。结论血塞通注射液联合增强型体外反搏应用于缺血性脑血管病患者中的效果显著,可减轻炎症反应,改善血管内皮功能,促进神经功能的恢复。
Objective To analyze the value of Xuesaitong injection combined with enhanced extracorporeal counterpulsation in the treatment of ischemic cerebrovascular disease.Methods A total of 110 patients with ischemic cerebrovascular disease admitted in our hospital were selected and randomly divided into control group and combined group, with 55 cases in each group. The control group was treated with enhanced extracorporeal counterpulsation, while the combined group was treated with Xuesaitong injection on the basis of the control group. The clinical effects, hypersensitivity C reactive protein（hs-CPR）, endothelin（ET-1） levels and neurological function scores of the two groups before and after treatment were compared.Results After treatment, the levels of hs-CPR, ET-1 and the NHISS scores in the two groups decreased, those in the combined group were lower than the control group（P〈0.05）. The total effective rate of treatment in the combined group was higher than that of the control group（P〈0.05）.Conclusion The combination of Xuesaitong injection and enhanced extracorporeal counterpulsation has significant effect, which can reduce inflammation, improve endothelial function and promote recovery of nerve function.
作者
王西愿
高佩佩
WANG Xi-yuan;GAO Pei-pei(Xianyang Hospital of Yan＇an University,Xianyang 712000,China)
出处
《临床医学研究与实践》
2018年第20期28-29,共2页
Clinical Research and Practice
关键词
缺血性脑血管疾病
血塞通注射液
增强型体外反搏
ischemic cerebrovascular disease
Xuesaitong injection
enhanced extracorporeal counterpulsation
